Reported 0 shares, down 14,000 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
|
This position's reported history falls outside the five-year preview window. A free account unlocks it.
Unlock full history
|
|||||||
Who else reported the position
8 managers reported BIOMARIN PHARMACEUTICAL INC for Q3 2015.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BAKER BROS ADVISORS LP | Unchanged | 22,379,000 | 0 | 1.07% | $115,619,000 | 10 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Unchanged | 1,000,000 | 0 | < 0.01% | $5,179,000 | 10 qtrs |
| UBS Group AG | Unchanged | 22,000 | 0 | < 0.01% | $112,000 | 4 qtrs |
| ROYAL BANK OF CANADA | Unchanged | 2,000 | 0 | < 0.01% | $10,000 | 10 qtrs |
| Bank of America Corporation | Unchanged | 2,000 | 0 | < 0.01% | $10,000 | 10 qtrs |
| Crosspoint Capital Strategies LLC | New | 1,000 | +1,000 | < 0.01% | $5,000 | 1 qtr |
| BANK OF MONTREAL | Unchanged | 1,000 | 0 | 0 | $0 | 10 qtrs |
| MORGAN STANLEY This report | Reduced | 0 | -14,000 | 0 | $0 | 4 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2015
- Filed
- November 09, 2015
- Filing type
- 13F-HR
- Position type
- NOTE 1.875% 4/2
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.